Navigating mHSPC Care: Hormone Therapy, Patient Relationships, and Multidisciplinary Communication

7 Views
Published
A roundtable discussion, moderated by Jigarkumar Parikh, MD, MBBS, highlighted the evolving landscape of prostate cancer treatment through the integration of multi-specialty collaboration, the introduction of new therapies and their challenges, and the crucial role of molecular and genetic testing in personalizing patient care and improving long-term outcomes. Dr. Parikh was joined by Joshua Perkel, MD; Rajesh Laungani, MD; Joseph Bear, MD; and Marc Greenstein, DO.

In the second segment of the roundtable series, the panel shares insights on managing mHSPC, emphasizing the importance of effective patient communication and the evolving role of novel therapies, while addressing the impact of hormone treatments on quality of life and the need for improved coordination between urologists and medical oncologists.
Category
Urology
Be the first to comment